Pretreatment with a novel Toll-like receptor 4 agonist attenuates renal ischemia-reperfusion injury.
Hernandez A, Patil NK, Brewer M, Delgado R, Himmel L, Lopez LN, Bohannon JK, Owen AM, Sherwood ER, de Caestecker MP.
Hernandez A, et al. Among authors: patil nk.
Am J Physiol Renal Physiol. 2023 May 1;324(5):F472-F482. doi: 10.1152/ajprenal.00248.2022. Epub 2023 Mar 30.
Am J Physiol Renal Physiol. 2023.
PMID: 36995924
Free PMC article.